BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 21851899)

  • 1. Clinical outcomes using a new crossover balloon occlusion technique for percutaneous closure after transfemoral aortic valve implantation.
    Genereux P; Kodali S; Leon MB; Smith CR; Ben-Gal Y; Kirtane AJ; Daneault B; Reiss GR; Moses JW; Williams MR
    JACC Cardiovasc Interv; 2011 Aug; 4(8):861-7. PubMed ID: 21851899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of routine crossover balloon occlusion technique on access-related vascular complications following transfemoral transcatheter aortic valve replacement.
    Zaman S; Gooley R; Cheng V; McCormick L; Meredith IT
    Catheter Cardiovasc Interv; 2016 Aug; 88(2):276-84. PubMed ID: 27107395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A "modified crossover technique" for vascular access management in high-risk patients undergoing transfemoral transcatheter aortic valve implantation.
    Buchanan GL; Chieffo A; Montorfano M; Maccagni D; Maisano F; Latib A; Covello RD; Grimaldi A; Alfieri O; Colombo A
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):579-83. PubMed ID: 22511470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Femoral access-related complications during percutaneous transcatheter aortic valve implantation comparing single versus double Prostar XL device closure.
    Saleh N; De Palma R; Settergren M; Rück A
    Catheter Cardiovasc Interv; 2015 Dec; 86(7):1255-61. PubMed ID: 26332528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct percutaneous access technique for transaxillary transcatheter aortic valve implantation: "the Hamburg Sankt Georg approach".
    Schäfer U; Ho Y; Frerker C; Schewel D; Sanchez-Quintana D; Schofer J; Bijuklic K; Meincke F; Thielsen T; Kreidel F; Kuck KH
    JACC Cardiovasc Interv; 2012 May; 5(5):477-486. PubMed ID: 22625184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new technique for vascular access management in transcatheter aortic valve implantation.
    Sharp AS; Michev I; Maisano F; Taramasso M; Godino C; Latib A; Denti P; Dorigo E; Giacomini A; Iaci G; Manca M; Ielasi A; Montorfano M; Alfieri O; Colombo A
    Catheter Cardiovasc Interv; 2010 Apr; 75(5):784-93. PubMed ID: 20049970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple, effective and safe vascular access site closure with the double-ProGlide preclose technique in 162 patients receiving transfemoral transcatheter aortic valve implantation.
    Griese DP; Reents W; Diegeler A; Kerber S; Babin-Ebell J
    Catheter Cardiovasc Interv; 2013 Nov; 82(5):E734-41. PubMed ID: 23765732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete percutaneous approach for arterial access in transfemoral transcatheter aortic valve replacement: a comparison with surgical cut-down and closure.
    Nakamura M; Chakravarty T; Jilaihawi H; Doctor N; Dohad S; Fontana G; Cheng W; Makkar RR
    Catheter Cardiovasc Interv; 2014 Aug; 84(2):293-300. PubMed ID: 23873857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transfemoral aortic valve replacement with the Edwards SAPIEN and Edwards SAPIEN XT prosthesis using exclusively local anesthesia and fluoroscopic guidance: feasibility and 30-day outcomes.
    Durand E; Borz B; Godin M; Tron C; Litzler PY; Bessou JP; Bejar K; Fraccaro C; Sanchez-Giron C; Dacher JN; Bauer F; Cribier A; Eltchaninoff H
    JACC Cardiovasc Interv; 2012 May; 5(5):461-467. PubMed ID: 22560979
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transfemoral aortic valve implantation new criteria to predict vascular complications.
    Hayashida K; Lefèvre T; Chevalier B; Hovasse T; Romano M; Garot P; Mylotte D; Uribe J; Farge A; Donzeau-Gouge P; Bouvier E; Cormier B; Morice MC
    JACC Cardiovasc Interv; 2011 Aug; 4(8):851-8. PubMed ID: 21851897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suture-mediated arterial access site closure after transfemoral aortic valve implantation.
    Kahlert P; Al-Rashid F; Plicht B; Konorza T; Neumann T; Thielmann M; Wendt D; Erbel R; Eggebrecht H
    Catheter Cardiovasc Interv; 2013 Feb; 81(2):E139-50. PubMed ID: 22553193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Bocksch W; Grossmann B; Geisler T; Steeg M; Droppa M; Jorbenadze R; Haap M; Gawaz M; Fateh-Moghadam S
    Catheter Cardiovasc Interv; 2016 Sep; 88(3):466-75. PubMed ID: 27184353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the femoral and radial crossover techniques for vascular access management in transcatheter aortic valve implantation: the Milan experience.
    Curran H; Chieffo A; Buchanan GL; Bernelli C; Montorfano M; Maisano F; Latib A; Maccagni D; Carlino M; Figini F; Cioni M; La Canna G; Covello RD; Franco A; Gerli C; Alfieri O; Colombo A
    Catheter Cardiovasc Interv; 2014 Jan; 83(1):156-61. PubMed ID: 23475626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of vascular complications following transcatheter aortic valve implantation.
    Perrin N; Ellenberger C; Licker M; Hachulla AL; Cikirikcioglu M; Frei A; Roffi M; Noble S
    Arch Cardiovasc Dis; 2015 Oct; 108(10):491-501. PubMed ID: 26073229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large calibre arterial access device closure for percutaneous aortic valve interventions: use of the Prostar system in 118 cases.
    Cockburn J; de Belder A; Brooks M; Hutchinson N; Hill A; Trivedi U; Hildick-Smith D
    Catheter Cardiovasc Interv; 2012 Jan; 79(1):143-9. PubMed ID: 21538787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiographic Analysis of Vascular Integrity After Percutaneous Closure Using Prostar XL Device During Transcatheter Aortic Valve Implantation.
    Lareyre F; Raffort J; Dommerc C; Benhammamia M; Bourlon F; Habib Y; Mialhe C
    Vasc Endovascular Surg; 2017 Jul; 51(5):282-287. PubMed ID: 28474978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First experience with a new balloon-expandable and re-collapsible vascular sheath in transfemoral percutaneous aortic valve replacement.
    Sedaghat A; Sinning JM; Werner N
    Catheter Cardiovasc Interv; 2013 Oct; 82(4):E613-6. PubMed ID: 23460472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience.
    Godino C; Maisano F; Montorfano M; Latib A; Chieffo A; Michev I; Al-Lamee R; Bande M; Mussardo M; Arioli F; Ielasi A; Cioni M; Taramasso M; Arendar I; Grimaldi A; Spagnolo P; Zangrillo A; La Canna G; Alfieri O; Colombo A
    JACC Cardiovasc Interv; 2010 Nov; 3(11):1110-21. PubMed ID: 21087745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of suture-based vascular closure devices in transfemoral transcatheter aortic valve implantation.
    Barbanti M; Capranzano P; Ohno Y; Gulino S; Sgroi C; Immè S; Tamburino C; Cannata S; Patanè M; Di Stefano D; Todaro D; Di Simone E; Deste W; Gargiulo G; Capodanno D; Grasso C; Tamburino C
    EuroIntervention; 2015 Oct; 11(6):690-7. PubMed ID: 26499222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ipsilateral arterial access for management of vascular complication in transcatheter aortic valve implantation.
    Frerker C; Schewel D; Kuck KH; Schäfer U
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):592-602. PubMed ID: 22707413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.